The Subject Expert Committee on Covid-19 has granted emergency use approval to Bharat Biotech’s Covaxin for children in the 2-18 years age group.
An expert panel on Tuesday recommended Covaxin – Bharat Biotech’s COVID-19 vaccine for use on children between the ages of two and 18.
Final approval for the use of Covaxin on children will be given by the Drug Controller General of India.
When that approval does come, Covaxin will become only second vaccine cleared for use on kids; in August Zydus Cadila’s three-dose DNA jab was allowed to be used on adults and children over 12.
